conspectus of researchon copper metabolism and requirements

2040 KARL E. MASON
23. Ardelt, W., Dehnhard, F. & Shussler, J.
( 1973 ) Serumkupfer und hitzestabile alka
lische Phosphatase bei normaler und patho
logischer Schwangerschaft. Ztschr. Geburt
shilfe Perinatal. 177, 188-192.
24. Arima, M. & Komiya, K. (1970) Preven
tion of Wilson's disease: a long term followup.
Paediatr. Univ. Tokyo 18, 22-24.
25. Ashkenazi, A., Levin, S., Djaldetti, M.,
Fishel, E. & Benvenisti, D. (1973) The
syndrome of neonatal copper deficiency.
Pediatrics 52, 525-533.
26. Asling, C. W. & Hurley, L. S. (1963) The
influence of trace elements on the skeleton.
Clin. Orthop. Related Res. 27, 213-262.
27. Axtrup, S. (1946) The Blood Copper in
Anaemias of Children with Special Reference
to Premature Cases. P. H. Lindstedts Universitets-Bokhandel,
Lund.
28. Baerlocher, K., Nussbaumer, A., Werder,
E. A. & Spycher, M. (1974) Menkes'
kinky hair disease: confirmation of copper
deficiency. Pediat. Res. 8, 135.
29. Bajpayee, D. P. (1975) Significance of
plasma copper and caeruloplasmin concen
trations in rheumatoid arthritis. Ann. Rheum.
Dis. 34, 163-165.
30. Bakwin, R. M., Mosbach, E. H. & Bakwin,
H. ( 1958 ) Ceruloplasmin activity in serum
of children with schizophrenia. Pediatrics
22, 905-909.
31. Bakwin, R. M., Mosbach, E. H. & Bakwin,
H. ( 1961 ) Concentration of copper in
serum of children with schizophrenia. Pedi
atrics 27, 642-644.
32. Baldassi, G. ( 1940 ) Le funzioni biologiche
del rame (Rassegna). Quad. Nutrizione 7,
250-270.
33. Baldi, E. M. & Gonzales-Somoza, E. ( 1957)
Enfermedad de Wilson y ciclo gravidopuerperal.
Obst. Ginecol. Latino-Amer. 15, 27-
31.
34. Barrass, B. C., Coult, D. B. & Pinder, R. M.
( 1972 ) 3-Hydroxy-4-methoxyphenethylamine:
the endogenous toxin of parkinsonism?
J. Pharm. Pharmacol. 24, 499-501.
35. Baum, & Seeliger (1898) Die chronische
Kupfergiftung. Arch. Thierheilk. 24, 80-127.
36. Beam, A. G. (1953) Genetic and bio
chemical aspects of Wilson's disease. Am. J.
Med. 15, 442-449.
37. Beam, A. G. (1957) Wilson's disease.
An inborn error of metabolism with multiple
manifestations. Amer. J. Med. 22, 747-757.
38. Beam, A. G. (1960) A genetical analysis
of 30 families with Wilson's disease (hepato-
lenticular degeneration). Ann. Hum. Genet.
24, 33-43.
39. Beam, A. G. & Kunkel, H. G. (1952) Bio
chemical abnormalities in Wilson's disease.
J. Clin. Invest. 31, 616.
40. Beam, A. G. & Kunkel, H. G. (1954)
Localization of MCu in serum fractions fol
lowing oral administration: an alteration in
Wilson's disease. Proc. Soc. Exp. Biol. &
Med. 85, 44-48.
41. Beam, A. G. & Kunkel, H. G. (1955)
Metabolism studies in Wilson's disease using
"Cu J. Lab. Clin. Med. 45, 623-631.
42.
L.
Beckner,
& O'Reilly,
W. M.,
S.
Strickland,
(1969) External
G. T., Leu
gamma
M
scintillation
and other
counting
sites in
of "7Cu over
patients with
the liver
Wilson's
disease, family members
Nucí.Med. 10, 320.
and controls. T.
43. Beinert, H. (1966) Cytochrome c oxidase:
present knowledge of the state and function
of its copper components. In: The Biochem
istry of Copper (Peisach, J., Aisen, P. &
Blumberg, W. E., eds.), pp. 213-234, Aca
demic Press, New York.
44. Beisel, W. R. & Pekarek, R.
Acute stress and trace element
Internat. Rev. Neurobiol. Suppl.
S. (1972)
metabolism.
1, 53-82.
45. Bergstrom,
S. (1972)
K., Bloomstrand, R. & Jacobson,
Long-term complete intravenous
nutrition
118-149.
in man. Nutr. Metab. 14, (Suppl.),
46. Bickel, H., Neale, F. C. & Hall, G. (1957)
A clinical and biochemical study of hepatolenticular
degeneration (Wilson's disease)
Quart. J. Med. 26, 527-558.
47. Bihl, J. H. (1959) The effect of preg
nancy
son's disease).
on hepatolenticular
Report of
degeneration
a case. Amer.
(Wil
J.
Obst. & Gynecol. 78, 1182-1188.
48. Billingham, M. E. J. & Gordon, A. H.
( 1976 ) The role of the acute phase reac
tions in inflammation. Agents Actions 6,
195-199.
49. Billings, D. M. & Degnan, M. (1971)
Kinky hair syndrome. A new case and a re
view. Am. J. Dis. Child. 121, 447-449.
50. Bloomfield, J. (1969) Copper
tion in exchange transfusions.
731-732.
contamina
Lancet 1.
51. Bloomfield, J., Dixon, S. R. & McCredie, D.
A. (1971) Potential hepatotoxicity of cop
per in recurrent hemodialysis. Arch. Int. Med.
128, 555-560.
52. Bloomfield, J., McPherson, J. & George, C.
R. P. (1969) Active uptake of copper
and zinc during haemodialysis. Brit. Med. J.
2, 141-145.
53. Bober-Vandzhura, I. P. (1968) Copper
metabolism in atherosclerotic
Arh. 40, 64-66 (Russian).
patients. Terap.
54. Borglin, N. E. & Heijkenskjold, F. (1967)
Studies on serum copper in pregnancy. Acta
Obstet. Gynecol. Scand. 46, 119-125.
55. Bourgeois, J., Galy, G., Baltassat, P. &
Béthenod,M. ( 1974 ) Maladie de Menkes.
Etude métabolismedu cuivre dans une ob
servation personnelle. Pédiatrie29, 573-594.
56. Bourgeois, J., Vittori, F., Collombel, C. &
Béthenod,M.
Présentation clinique
(1974)
d'une
^ Maladie
observation
de Menkes.
per
sonelle. Pediatrie 29, 561-572.
56a. Bowering, J., Sanchez, A. M. & Irwin, M. I.
(1976) A conspectus of research on iron
requirements of man. J. Nutr. 106, 985-1074.
57. Bozian, R. C. & Shearer, C. (1976) Cop
per, zinc and manganese content of four
Downloaded from
jn.nutrition.org
by guest on February 27, 2013